INDGN
NSEIndegene Limited (SMALL CAP)
Healthcare>Healthcare>Healthcare Services>Healthcare Research Analytics & Technology
₹510.35
3.60 (0.71%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹12.27K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
30.4
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Healthcare Research Analytics & Technology
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹414+23.3%
52W High₹620.2-17.7%
Current Price
₹510.35
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹408.28
Upper Circuit₹612.42
Reference Price
₹510.35
Investment Checklist
Double Top on 1W (BREAKOUT CONFIRMED) — target ₹475.2
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹475.0
10/20 Bullish Cross detected 4 day(s) ago
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
44%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
515.06
EMA50
506.34
EMA200
517.77
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows6
Lower Highs4
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹533.06
₹544.00
₹559.53
₹590.68
₹620.20
Support (Below)
₹507.14
₹480.58
₹459.75
₹432.80
₹423.00
Volume Analysis
TrendINCREASING
Change+13.40%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bullish Cross
4 days ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹505.25
3% Risk₹495.04
5% Risk₹484.83
7% Risk (Custom)
₹474.63Technical Levels
1x ATR (Volatility)₹494.45
2x ATR (Swing)₹478.55
3x ATR (Trend)₹462.65
Immediate Support₹507.14
Moving Averages
EMA 50 (Trend)₹506.34
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹720.4 Cr | ₹755.6 Cr | ₹760.8 Cr | ₹942.1 Cr |
| Net Profit | ₹109.7 Cr | ₹117.6 Cr | ₹116.4 Cr | ₹102.9 Cr |
| EPS | ₹4.59 | — | ₹4.86 | ₹4.29 |
| Operating Profit | ₹169.5 Cr | ₹173.1 Cr | ₹177.4 Cr | ₹178.9 Cr |
Peer Comparison
Healthcare Research Analytics & TechnologyCorporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 13 Jun 2025 | Dividend - Rs 2 Per Share | DIVIDEND |
| 29 Aug 2024 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for INDGN
View All
positive
CNBC TV18 - Markets 44d ago
Indegene Q4 net profit falls 32% despite record ₹1,003 crore revenue, declares dividend
Shares of Indegene Ltd ended at ₹497.70, down by ₹2.05, or 0.41%, on the BSE.
BSEDIVIDENDINDGNFinancial ServicesHealthcare
positive
CNBC TV18 - Markets 44d ago
Q4 Results Highlights: Indegene profit falls 32%, RPG Life revenue up 24%
Q4 Results Highlights: Major companies including Bajaj Finance, Adani Power, Vedanta, MOIL, Mphasis, Navin Fluorine, Waaree Energies and Bandhan Bank reported their Q4 earnings on Wednesday, while a host of financial, energy and midcap firms also announced results, keeping markets active ahead of a holiday-shortened week.
ABSLBANETFADANIENSOLADANIENTADANIGREENADANIPOWERAUBANKBAJAJHFLBAJFINANCEBANDHANBNKBANKBETFBANKINDIACAPITALSFBDPELENERGYEQUITASBNKESAFSFBGKENERGYGVPILINDGNJMFINANCILJSFBKPELLTFMIDCAPMOILMPHASISNAVINFLUORPFCRPGLIFESURYODAYUJJIVANSFBUTKARSHBNKVEDLWAAREEENERCapital GoodsChemicals
positive
Moneycontrol NaNd ago
Neutral Indegene; target of Rs 552: Motilal Oswal
Motilal Oswal recommended Neutral rating on Indegene with a target price of Rs 552 in its research report dated May 02, 2026.
INDGNMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare